4.6 Article

Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity

Journal

JOURNAL OF CLINICAL EPIDEMIOLOGY
Volume 66, Issue 4, Pages 408-414

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jclinepi.2012.09.016

Keywords

Risk of bias; Nonrandomized studies; Systematic reviews; Reliability; Validity; Validation studies

Funding

  1. National Evidence-Based Healthcare Collaborating Agency
  2. Health Insurance Review & Assessment Service of the Republic of Korea

Ask authors/readers for more resources

Objectives: To develop and validate a new risk-of-bias tool for nonrandomized studies (NRSs). Study Design and Setting: We developed the Risk of Bias Assessment Tool for Nonrandomized Studies (RoBANS). A validation process with 39 NRSs examined the reliability (interrater agreement), validity (the degree of correlation between the overall assessments of RoBANS and Methodological Index for Nonrandomized Studies [MINORS], obtained by plotting the overall risk of bias relative to effect size and funding source), face validity with eight experts, and completion time for the RoBANS approach. Results: RoBANS contains six domains: the selection of participants, confounding variables, the measurement of exposure, the blinding of the outcome assessments, incomplete outcome data, and selective outcome reporting. The interrater agreement of the RoBANS tool except the measurement of exposure and selective outcome reporting domains ranged from fair to substantial. There was a moderate correlation between the overall risks of bias determined using RoBANS and MINORS. The observed differences in effect sizes and funding sources among the assessed studies were not correlated with the overall risk of bias in these studies. The mean time required to complete RoBANS was approximately 10 min. The external experts who were interviewed evaluated RoBANS as a fair assessment tool. Conclusions: RoBANS shows moderate reliability, promising feasibility, and validity. The further refinement of this tool and larger validation studies are required. (C) 2013 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available